Therapeutic Vaccine Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Therapeutic Vaccine Market
Therapeutic Vaccine Market: By Vaccine Type (Addiction, Neurological, Infectious, Autoimmune); By Technology (Autologous, Allogenic) & By region - Forecast(2018 - 2023)
Report Code : HCR 0397
Updated Date: 31 May, 2018  

1. Therapeutic Vaccine Market – Overview
2. Executive Summary
3. Therapeutic Vaccine Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Therapeutic Vaccine Market– Forces
   4.1. Drivers
      4.1.1. Increasing cases of cancer and HIV diseases
   4.2. Restraints
      4.2.1. Strict regulations in developed nations
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Therapeutic Vaccine Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Therapeutic Vaccine Market, By Type
   6.1. Addiction Vaccines
      6.1.1. Cocaine Addiction Vaccines
      6.1.2. Nicotine Addiction Vaccines
   6.2. Autoimmune Disease Vaccines
      6.2.1. Diabetes (Type 1)
            6.2.1.1. Diamyd (RHGAD65)
            6.2.1.2. BHT-3021
            6.2.1.3. Tovaxin
            6.2.1.4. TNFaKinoid
      6.2.2. Cancer Vaccines
            6.2.2.1. Cancer vaccines in development
            6.2.2.2. Cancer vaccines approved for use
   6.3. Infectious Disease Vaccines
      6.3.1. HIV/AIDS
      6.3.2. Other infectious disease vaccines (outside HIV)
      6.3.3. Hepatitis C
   6.4. Neurological disease vaccines
      6.4.1. Parkinson’s disease vaccine
      6.4.2. Other disease vaccines
7. Therapeutic Vaccine Market, By Technology
   7.1. Autologous Vaccine
   7.2. Allogeneic Vaccine
8. Therapeutic Vaccine Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Therapeutic Vaccine Market – Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. Agenus, Inc.
   10.2. GlaxoSmithKline
   10.3. Novartis AG
   10.4. Pfizer
   10.5. Argos Therapeutic Inc.
   10.6. Merck & Co.
   10.7. Celldex Therapeutic Inc.
   10.8. Cytos Biotechnology AG
   10.9. Dendreon Corp
   10.10. Vaccinogen, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll